: constance.shen@shine-consultant.com官网：http://www.shine-consultant.com/prod_view.aspx?TypeId=31&Id=275&amp...大咖齐聚北京丨1月21-22日亚洲医药研发领袖峰会 开幕在即！ 经过近半年紧锣密鼓的筹备, 由士研咨询

AJG：A12-week,randomized,controlledtrialwitha4-weekrandomizedwithdrawalperiodto 

        分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
 BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
 

://www.onyx.com获取。 003-A1研究的相关信息总共有266位已经接受了至少两种治疗包括bortezomib和免疫调节剂的复发性多发性骨髓瘤...奥尼克斯制药公司宣布，美国血液协会的医学杂志已经发表了003-A1phase 2b 试验的结果，这是一个评估Kyprolis注射治疗 后阶段

于评价左室舒张功能。正常人 E/A>1，且 DT<220ms，EA＜1 提示有可能有舒张功能受损，具体解读见下篇。（3）TDI 测量评价心脏舒张功能近年研究发现采用 TDI 对于评价心脏舒张功能更为准确，具体解读见下篇。6.通过 M 超或 B 超测量后的室壁运动分析7. 心超的结论报告临床医生须知

采用放疗来治疗初始大型疾病”从2B级改为2A级推荐意见。Zelenetz博士声明担任CancerGenetics和Gilead...佛罗里达州好莱坞——美国国家综合癌症网络（NCCN）最近更新了弥漫大B细胞淋巴瘤（DLBCL）指南，纳入致癌基因MYC作为

/人（统一安排食宿）；2012年6月26日前于网上完成注册（http://www.cdnjhw.com/）并成功缴费的代表，方能保证安排住宿。3. 会议主席团成员享受免会务费、大会统一安排食宿的待遇，但仍须提前网上注册（http://www.cdnjhw.com/）或电话、短信联系以便预留房间（有学术任务并已先期联系

：1.新药7月份CDE共承办新的化药新药注册申请以受理号计有211个，与上个月（179个）相比有所增加。（1）1.1类新药① 申报受理情况7月份共有5...衍生物，由广州喜鹊医药有限公司和暨南大学联合开发。根据暨南大学申请的专利（专利号CN 101468970 B和CN 102311396 A）以及相关文献和报道显示

;in spontaneous pneumothoraxObjective: We assessed in a randomized study the feasibility... and June 2005, a total of 43 patients with primary spontaneous pneumothorax were

://www.nature.com/articles/s41565-021-00897-1...「这一发现表明，我们可能能够诱使癌细胞进入营养缺乏状态，从而增加它们对 [白蛋白结合的抗癌药物] 的消耗。」——麻省总医院系统生物学中心 Ran Li 博士

最近，胸主动脉腔内修复治疗胸主动脉瘤越来越普遍。然而，对于慢性 B 型主动脉夹层，其中内脏动脉起源于假腔的患者，来源于假腔的血流并不一定堵塞，且返流的血液可使...高度同时处理支架。为了保证植入架近端长度，将近端延伸袖送到一侧，另一袖送到另一侧（图 1）。通过 Coda 球囊导管使其同时扩张。术中血管造影术，术后 CT

2pm～5pm在中山楼7楼707室或26日8am在岭南楼26楼海珠厅。办班地点：中山大学孙逸仙纪念医院（附属第二医院）岭南楼26楼海珠厅。招生...医院岭南楼26楼海珠厅上课时间：上午8:30am～12:00am，下午2:30pm～5:30pm，晚上7:00pm～10:00pm。备注：课程表及手术演示

LAMA4，JUN,ATR,FOXO3a，ETS1和SORBS2基因可能为调节肾透明细胞癌发生远处转移的关键基因。通过文献分析基因功能，我们针对FOXO3基因进行...在SN12-PM6转移细胞中过表达FOXO3a基因可明显抑制其在裸鼠动物模型中发生远处转移。敲低FOXO3a基因表达可以增加SNAIL1基因的表达，进而激活肾癌

3 月 30 日，国家卫生健康委公布 2019 年度国家三级公立医院绩效考核（以下简称「国考」）国家监测指标考核结果。上海市第一人民医院获 A++最高考评等级，在全国 2413 家三级公立医院中位列综合医院类第 12 名，位居全国前 1%。2019 年国务院办公厅发布《关于加强三级公立医院绩效考核工作的意见

低预混与中预混胰岛素如何选择的问题。研究为何设置观察 26 周？入组前患者用药情况如何？研究中提到了碳水化合物比例与热量，具体是如何操作的？餐前血糖对 HbA1c 达标贡献很大吗？临床上应该如何区分优泌乐 50 与优泌乐 25 的使用人群？窦京涛教授将从临床医生角度向 CLASSIFY 研究牵头人杨文英教授提问，杨教授

学习班费用：800元/人。因动物实验费用较高，拟参加动物实验和腹腔镜模拟培训的学员，请提前与会务组联系并将视实验进行情况，适当提高学习费用。联系人：王刚，报名邮箱：pedsurg.cn@163.com，电话：15168860120详见学习班专题网站：www.pedsurgcn.com

提交给会务组，于7月18日前将电子版论文全文发至yycxxh@126.com信箱。五、 联系人： 王 峰&nbsp...：www.chinazxy.org备注：一、会后组织免费香港两日考察：食宿行免费。二、（港澳4天3晚考察：费用650元、台湾环岛考察8天7晚：9800元

和 FITC 的光谱重叠最小，可以在多色分析中与PE 和 FITC 标记的抗体结合使用。图 1. Annexin V/7-AAD 凋亡检测试剂盒原理在早期...盒APK10448-P100 Tests参考文献1. Carlos A Ramos, Gianpietro Dotti. Chimeric antigen

帕金森相关症状的可能，超过 50 mg 的会产生明显影响，超过 750 mg 则几乎使左旋多巴无效[1]。鉴于日常生活饮食中维生素 B6 的存在，我们不可能做到其「零」摄入，而我国对于 1 岁至 80 岁人群的维生素 B6 每日饮食推荐量为 0.6-1.6 mg[2]。帕金森患者或其它运动障碍性疾病需要服用